Introducing the Seed Grant Ramsay Award Program

The Solve ME/CFS Initiative (SMCI) is now accepting applications for the Ramsay Award Program in basic, preclinical, clinical, and epidemiology research. This competitive grant award is open to scientists and researchers at any career stage who are interested in studying myalgic encephalomyelitis (ME)/chronic fatigue syndrome (CFS). The program is named for ME pioneer Dr. A. Melvin Ramsay, who remained a staunch advocate for the plight of ME/CFS patients until his passing in 1990.
It is anticipated that Ramsay Award Program grants will be made annually. Individual awards are expected to range between $35,000 and $55,000 for a one-year period, with the possibility of renewal for projects yielding promising results.
In short, the program has three main objectives:

  • Invest in original ideas that could clarify the onset, progression, root causes, and natural history of ME/CFS
  • Create open environments to attract, support, and retain scientific talent in the ME/CFS community and help awardees generate data to compete for long-term ME/CFS federal funding
  • Facilitate collaboration among dedicated researchers through the sharing of resources and access to additional programming

For researchers, this investment in seed grants through an open competition reflects SMCI’s commitment to participatory research and inclusivity toward advancing the field and amplifying the impact of good science.
SMCI is specifically encouraging applications that address key gaps in current scientific knowledge, such as energy system defects, biochemical processing of ATP-bound substrates, nutrient sensing and signaling mechanisms, neuroinflammation, endocrine biology, cellular and systemic immunity, host/pathogen interaction, gut/brain axis, microbiome research, post-exertional malaise (PEM), orthostatic intolerance (OI), and sleep abnormalities.
“The Ramsay Award Program is part of our organization’s overall research strategy to encourage participatory investigations, accelerate new discoveries, and reduce barriers for entry into the challenging yet rewarding field of ME/CFS,” said Dr. Zaher Nahle, SMCI’s vice president for research and scientific programs.
Submitted proposals will be subject to a rigorous peer review process in order to ensure that only applications of the highest merit are funded. Proposals are due on Friday, July 29, 2016. Please consult http://solvecfs.org/ramsay-award-program-rfa to learn more and download the application.

Facebook
Twitter
WhatsApp
Email

2 thoughts on “Introducing the Seed Grant Ramsay Award Program”

    1. Thanks, Kandice! We also have a weekly update called “SMCI This Week” which goes out on Fridays. It contains a weekly summary of news items like these. You can sign up at solvecfs.org

Comments are closed.

Latest News

comic book background with yellow and blue colors with dots. In the center is a starburst with the words 2024 advocacy highlights. the middle is surrounded with exclamation marks.

Why You Should Gift to #MEAction this Season

As #MEAction prepares for the year ahead, I’m thrilled to share with you a few highlights from the incredible advocacy projects our staff has undertaken this past year.  As you prepare for the holidays, I humbly ask that you consider making a gift to #MEAction today to keep our work going strong! Donate We Organized

Read More »
burnt red square. there is a quote bubble in the center of the image with the words: Take Action Today: Support Keeping Telehealth! Surrounding the bubble is a megaphone in the bottom left corder and lightning bolts in the top right corner. and starburst as well. the meaction logo in the bottom right corner.

Support Keeping Telehealth – Take Action Today!

Expanded telehealth coverage for Medicare is set to expire at the end of this year, December 31st! Learn More #MEAction knows losing expanded telehealth will be a problem for many in our community and the wider disability community. While this action focuses on keeping the expanded Medicare coverage for telemedicine, we know that what Medicare

Read More »
Scroll to Top